Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has announced that Slater Investments has altered its stake in the company, resulting in a change in voting rights. The notification indicates that the threshold was crossed on October 4, 2023, with Slater Investments now holding an 11.04% voting right in Alliance Pharma. This move signifies a notable increase from the previous notification, where Slater Investments held a 10.02% voting right.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
